Clinical Trial Update: Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing denosumab with zoledronic acid in postmenopausal osteoporosis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Amgen | Conditions: Post Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-01-25